PriceTargets.com logo

Ceridian HCM - CDAY Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$69.10 As of 12/3/2025 01:00 AM ET
▼ -0.01 (-0.01%)

This chart shows the closing price for CDAY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ceridian HCM Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CDAY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CDAY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Ceridian HCM in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $69.10.

This chart shows the closing price for CDAY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Ceridian HCM. This rating has held steady since January 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/19/2024Robert W. BairdReiterated RatingOutperform ➝ Outperform$86.00
1/10/2024Stifel NicolausInitiated CoverageBuy$75.00
12/5/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$82.00
11/7/2023UBS GroupInitiated CoverageBuy$87.00
11/2/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$82.00
11/2/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$65.00 ➝ $62.00
10/23/2023The Goldman Sachs GroupInitiated CoverageNeutral$74.00
10/12/2023Piper SandlerReiterated RatingNeutral ➝ Neutral$73.00
10/5/2023Needham & Company LLCUpgradeHold ➝ Buy$82.00
8/3/2023Piper SandlerBoost TargetNeutral ➝ Neutral$70.00 ➝ $73.00
8/3/2023BarclaysBoost TargetEqual Weight ➝ Equal Weight$73.00 ➝ $74.00
7/21/2023CitigroupBoost TargetBuy$74.00 ➝ $84.00
7/13/2023TD CowenDowngradeOutperform ➝ Market Perform$69.00 ➝ $71.00
5/4/2023DA DavidsonLower Target$86.00 ➝ $77.00
5/4/2023Credit Suisse GroupLower Target$105.00 ➝ $83.00
5/4/2023Wells Fargo & CompanyLower Target$75.00 ➝ $65.00
5/4/2023BarclaysLower Target$74.00 ➝ $73.00
2/10/2023Robert W. BairdBoost TargetOutperform$78.00 ➝ $86.00
2/9/2023Deutsche Bank AktiengesellschaftBoost Target$82.00 ➝ $90.00
2/9/2023BMO Capital MarketsBoost TargetOutperform$73.00 ➝ $86.00
2/9/2023CowenBoost TargetOutperform$77.00 ➝ $87.00
2/9/2023Wells Fargo & CompanyBoost TargetEqual Weight$65.00 ➝ $75.00
2/9/2023MizuhoBoost TargetBuy$80.00 ➝ $95.00
2/9/2023Credit Suisse GroupBoost TargetOutperform$90.00 ➝ $105.00
2/9/2023Piper SandlerBoost TargetNeutral$60.00 ➝ $78.00
2/9/2023BarclaysBoost TargetEqual Weight$64.00 ➝ $74.00
1/23/2023Deutsche Bank AktiengesellschaftBoost Target$80.00 ➝ $82.00
1/10/2023BarclaysLower TargetEqual Weight$66.00 ➝ $64.00
1/9/2023Moffett NathansonInitiated CoverageMarket Perform$68.00
11/14/2022CowenBoost TargetOutperform$70.00 ➝ $77.00
11/14/2022CowenBoost TargetOutperform$70.00 ➝ $77.00
11/3/2022JPMorgan Chase & Co.Lower TargetNeutral$75.00 ➝ $70.00
11/3/2022CowenBoost Target$67.00 ➝ $70.00
11/3/2022CowenBoost Target$67.00 ➝ $70.00
10/31/2022BarclaysUpgradeUnderweight ➝ Equal Weight$54.00 ➝ $64.00
10/21/2022CitigroupLower Target$73.00 ➝ $68.00
10/18/2022BarclaysBoost TargetUnderweight$52.00 ➝ $54.00
9/1/2022CitigroupInitiated CoverageBuy$73.00
8/9/2022CowenBoost Target$72.00
8/4/2022BMO Capital MarketsBoost TargetOutperform$70.00 ➝ $73.00
8/4/2022Credit Suisse GroupBoost TargetOutperform$70.00 ➝ $75.00
8/4/2022Deutsche Bank AktiengesellschaftLower Target$85.00 ➝ $80.00
8/4/2022Piper SandlerBoost TargetNeutral$48.00 ➝ $60.00
7/18/2022Piper SandlerLower TargetNeutral$61.00 ➝ $48.00
7/18/2022BarclaysLower TargetUnderweight$59.00 ➝ $52.00
5/23/2022Jefferies Financial GroupLower Target$65.00 ➝ $56.00
5/9/2022MizuhoLower Target$100.00 ➝ $80.00
5/5/2022William BlairReiterated RatingOutperform
5/5/2022CowenLower Target$90.00 ➝ $75.00
5/5/2022BMO Capital MarketsLower Target$91.00 ➝ $83.00
5/5/2022Robert W. BairdLower Target$105.00 ➝ $80.00
5/5/2022CowenLower Target$90.00 ➝ $75.00
5/5/2022Deutsche Bank AktiengesellschaftLower Target$105.00 ➝ $85.00
4/19/2022BarclaysLower TargetUnderweight$83.00 ➝ $60.00
3/23/2022Credit Suisse GroupInitiated CoverageOutperform$85.00
3/15/2022Wells Fargo & CompanyLower TargetEqual Weight$85.00 ➝ $65.00
2/11/2022Wolfe ResearchDowngradePeer Perform ➝ Underperform
2/10/2022Deutsche Bank AktiengesellschaftLower TargetBuy$110.00 ➝ $105.00
2/10/2022Wells Fargo & CompanyLower TargetEqual Weight$100.00 ➝ $85.00
2/10/2022BarclaysLower TargetUnderweight$92.00 ➝ $83.00
2/10/2022Piper SandlerLower TargetNeutral$105.00 ➝ $85.00
2/2/2022BMO Capital MarketsInitiated CoverageOutperform$91.00
1/28/2022MizuhoLower TargetBuy$140.00 ➝ $100.00
1/21/2022Deutsche Bank AktiengesellschaftLower TargetBuy$150.00 ➝ $110.00
1/13/2022Piper SandlerLower TargetNeutral$114.00 ➝ $105.00
1/12/2022BarclaysLower TargetUnderweight$115.00 ➝ $92.00
1/6/2022Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$135.00 ➝ $100.00
11/4/2021BarclaysBoost TargetUnderweight$106.00 ➝ $115.00
11/4/2021Piper SandlerBoost TargetNeutral$110.00 ➝ $114.00
11/1/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$150.00
10/21/2021MizuhoBoost TargetBuy$130.00 ➝ $140.00
10/19/2021Jefferies Financial GroupReiterated RatingNeutral ➝ Hold
10/18/2021BarclaysBoost TargetUnderweight$105.00 ➝ $106.00
10/18/2021CowenBoost TargetOutperform$115.00 ➝ $135.00
10/13/2021DA DavidsonInitiated CoverageBuy$135.00
10/11/2021Wells Fargo & CompanyBoost TargetOverweight$115.00 ➝ $135.00
10/8/2021MizuhoBoost TargetBuy$120.00 ➝ $130.00
10/7/2021Needham & Company LLCReiterated RatingHold
9/22/2021Needham & Company LLCReiterated RatingHold
8/5/2021Piper SandlerBoost TargetNeutral$108.00 ➝ $110.00
8/5/2021Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$110.00 ➝ $115.00
6/30/2021BarclaysDowngradeEqual Weight ➝ Underweight$98.00
6/15/2021Needham & Company LLCDowngradeBuy ➝ Hold
5/28/2021Jefferies Financial GroupLower Target$110.00 ➝ $95.00
5/6/2021MizuhoBoost TargetBuy$110.00 ➝ $120.00
4/28/2021Wolfe ResearchInitiated CoverageOutperform$105.00
4/22/2021Wolfe ResearchInitiated CoverageOutperform$105.00
4/15/2021BarclaysLower TargetEqual Weight$108.00 ➝ $97.00
4/9/2021BarclaysUpgradeEqual Weight ➝ Positive$108.00 ➝ $97.00
2/16/2021BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$112.00 ➝ $115.00
2/10/2021Credit Suisse GroupLower TargetNeutral$100.00 ➝ $95.00
2/10/2021Needham & Company LLCBoost TargetBuy$105.00 ➝ $120.00
2/10/2021Wells Fargo & CompanyBoost TargetOverweight$101.00 ➝ $110.00
1/15/2021Credit Suisse GroupBoost TargetNeutral$86.00 ➝ $100.00
12/16/2020MizuhoBoost TargetBuy$100.00 ➝ $110.00
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.48 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Ceridian HCM logo
Ceridian HCM Holding Inc., together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources, payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market. The company also provides Bureau solutions for payroll and payroll-related services. It sells its solutions through direct sales force and third-party channels. The company was incorporated in 2013 and is headquartered in Minneapolis, Minnesota.
Read More

Today's Range

Now: $69.10
Low: $69.09
High: $69.20

50 Day Range

MA: $68.71
Low: $68.11
High: $69.12

52 Week Range

Now: $69.10
Low: $55.62
High: $79.66

Volume

3,621,940 shs

Average Volume

1,312,424 shs

Market Capitalization

$10.79 billion

P/E Ratio

2,304.10

Dividend Yield

N/A

Beta

1.38

Frequently Asked Questions

What sell-side analysts currently cover shares of Ceridian HCM?

The following sell-side analysts have issued reports on Ceridian HCM in the last year:
View the latest analyst ratings for CDAY.

What is the current price target for Ceridian HCM?

0 Wall Street analysts have set twelve-month price targets for Ceridian HCM in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Ceridian HCM in the next year.
View the latest price targets for CDAY.

What is the current consensus analyst rating for Ceridian HCM?

Ceridian HCM currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CDAY.

What other companies compete with Ceridian HCM?

Other companies that are similar to Ceridian HCM include CCC Intelligent Solutions, ZoomInfo Technologies, Smead Value C, Semrush and MiX Telematics. Learn More about companies similar to Ceridian HCM.

How do I contact Ceridian HCM's investor relations team?

Ceridian HCM's physical mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company's listed phone number is (952) 853-8100 and its investor relations email address is [email protected]. The official website for Ceridian HCM is www.ceridian.com. Learn More about contacing Ceridian HCM investor relations.